Clinical Trial Update: MT027 in Patients With Advanced Peritoneal Malignancies or Abdominal Metastatic Solid Tumors [Phase 1]

View source ↗

Summary

MT027 is being studied in a Phase 1 trial for patients with B7-H3-positive advanced malignant solid tumors, including primary peritoneal cancer and abdominal me…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Peritoneal Cancer
• Peritoneal Carcinomatosis

Drugs mentioned

• MT027

Snippet

Sponsor: Zhejiang University | Conditions: B7-H3-positive Advanced Malignant Solid Tumors Advanced Primary Peritoneal Tumors or Secondary Abdominal Metastatic Malignant Solid Tumors | Phase 1 | Status: RECRUITING